Historical record - last NADAC effective date: 3/23/2022
Product Information
TORSEMIDE 5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0835 per EA under NDC 57237013801. Its NADAC has been published 321 times since Feb 10, 2016.
FDA first approved this application on Oct 17, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Torsemide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237013801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
3/23/2022
Active Ingredients
TORSEMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078249FDA Approved
10/17/2007
TE Code
AB
On Market Since
10/17/2007
Pharmacological Classes
Price Statistics
The NADAC for TORSEMIDE 5 MG TABLET has been published 321 times since Feb 10, 2016, and over the history we have for it it has declined 34.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0835 per EA |
|---|---|
| All-time high | $0.1422 (Dec 14, 2016) |
| All-time low | $0.0580 (Aug 22, 2018) |
| Median price | $0.0818 |
| Average price | $0.0872 |
| Largest weekly change | +76.8% (Jun 20, 2018) |
| Weeks tracked | 321 |
| Tracking since | Feb 10, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-26.9%
All
-34.1%
Last surveyed Mar 30, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TORSEMIDE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TORSEMIDE 5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0835 per EA (NDC 57237013801), effective Mar 30, 2022.
How has the price of TORSEMIDE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TORSEMIDE 5 MG TABLET has declined 34.1%. It has been tracked across 321 weekly CMS publications since Feb 10, 2016.
What are the highest and lowest recorded NADAC prices for TORSEMIDE 5 MG TABLET?
Since Feb 10, 2016, the NADAC for TORSEMIDE 5 MG TABLET has ranged from a low of $0.0580 (Aug 22, 2018) to a high of $0.1422 (Dec 14, 2016), with a median of $0.0818 per EA.
Are there cheaper alternatives to TORSEMIDE 5 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TORSEMIDE 5 MG TABLET, is $0.0629 per EA — about 25% below TORSEMIDE 5 MG TABLET.
Who manufactures TORSEMIDE 5 MG TABLET?
TORSEMIDE 5 MG TABLET (NDC 57237013801) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.